Symbol="TERN"
AssetType="Common Stock"
Name="Terns Pharmaceuticals Inc"
Description="Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of nonalcoholic steatohepatitis (NASH) and other chronic liver diseases. The company is headquartered in Foster City, California."
CIK="1831363"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="316275000"
EBITDA="-79083000"
PERatio="None"
PEGRatio="None"
BookValue="4.489"
DividendPerShare="0"
DividendYield="0"
EPS="-1.25"
RevenuePerShareTTM="0.035"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.229"
ReturnOnEquityTTM="-0.35"
RevenueTTM="1000000"
GrossProfitTTM="1000000"
DilutedEPSTTM="-1.25"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="16.44"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="256.53"
PriceToBookRatio="1.339"
EVToRevenue="60.08"
EVToEBITDA="-1.033"
Beta="-1.11"
num_52WeekHigh="14.04"
num_52WeekLow="3.57"
num_50DayMovingAverage="8.38"
num_200DayMovingAverage="9.21"
SharesOutstanding="56680000"
DividendDate="None"
ExDividendDate="None"
symbol="TERN"
open="5.40"
high="5.71"
low="5.29"
price="5.58"
volume="1095450.00"
latest_trading_day="2023-08-18"
previous_close="5.49"
change="0.09"
change_percent="1.6393%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="39"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="61"
Volume_recent_avg="755327"
Change_recent_avg="-0.07"
Delta_recent_avg="0.8"
Variance_recent_avg="0.4"
Change_ratio_recent_avg="-0.97"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="61"
Aroon_momentum_negative="39"
image_negative_thumbnail_id_1="512"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0093.jpeg"
image_negative_thumbnail_id_2="129"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0047.jpeg"
image_neutral_thumbnail_id_1="595"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_neutral_thumbnail_id_2="539"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_positive_thumbnail_id_1="641"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0067.jpeg"
image_positive_thumbnail_id_2="1014"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0176.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
